The role of plasma presepsin levels in determining the incidence of septic shock and mortality in patients with sepsis
Open Access
- 31 January 2021
- journal article
- research article
- Published by Journal of Infection in Developing Countries in Journal of Infection in Developing Countries
- Vol. 15 (01), 123-130
- https://doi.org/10.3855/jidc.12963
Abstract
Introduction: The present study aimed to investigate the role of plasma presepsin in the early detection of septic shock and in determining the prognosis and mortality of patients with sepsis. Methodology: The study was conducted in the emergency department between 1 January 2017 and 1 July 2017. A total of 106 patients 18 years of age or older who were diagnosed with sepsis according to the quick sequential organ failure assessment (qSOFA) criteria were included in this prospective study. The patients’ symptoms, vital signs, additional diseases, demographic attributes, laboratory results, Mortality in Emergency Department Sepsis (MEDS) scores, imaging findings and treatments were recorded. Moreover, the patients’ blood samples were collected to measure plasma presepsin, procalcitonin and CRP levels. Results: In total, 55.7% of the patients were female. The median age of the patients was 78 (24–103) years, and their 30-day mortality rate was 67%. The presepsin level was significantly higher in the sepsis group than in the healthy control group (p < 0.001). The presepsin levels did not differ significantly between the sepsis and septic shock groups (p = 0.12). Similarly, the procalcitonin levels did not differ significantly between the sepsis and septic shock groups (p > 0.05). There was no significant difference in the presepsin, procalcitonin and CRP levels between survivor and non-survivor patients (p = 0.74). Conclusions: The plasma presepsin level was found to be ineffective in determining the incidence of septic shock and mortality in patients with sepsis in the emergency department.Keywords
This publication has 21 references indexed in Scilit:
- Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean populationJournal of Critical Care, 2014
- Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency DepartmentClinical Biochemistry, 2014
- Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency departmentCritical Care, 2013
- Characteristics and outcomes of culture-negative versus culture-positive severe sepsisCritical Care, 2013
- Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective studyCritical Care, 2013
- Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference rangesThe Journal of Maternal-Fetal & Neonatal Medicine, 2012
- Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patientscclm, 2011
- EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care unitsIntensive Care Medicine, 2004
- Current Epidemiology of Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Mortality in Emergency Department Sepsis (MEDS) score: A prospectively derived and validated clinical prediction rule*Critical Care Medicine, 2003